In this week’s edition of InnovationRx, we look at cheaper biologic drugs, Novo Nordisk’s $2 billion next-gen obesity drug deal, new ways of fighting cancer, and more.
Hot-mixed Roman concrete used quicklime “healing” clasts that seal cracks over time, explaining Pompeii’s long‑lasting structures and inspiring tougher, lower‑carbon concretes today.
Dr. Paul Limburg, gastroenterologist and CMO of Exact Sciences speaks on a non-invasive testing of colorectal cancer using Cologuard.
Medical spas offer IV hydration therapies with no known benefits and potentially serious harms
The Danish drugmaker is collaborating with Vivtex, cofounded by billionaire Robert Langer, to quickly iterate oral versions of successors to Ozempic and Wegovy.
There are political and safety considerations as the FDA looks to make more drugs OTC. Also, antibiotic resistance is a huge problem where those meds are OTC.
Five practical guardrails to get accurate, private and actionable health answers from AI chatbots — what to ask, what to avoid.
CRISPR gene therapy Casgevy can nearly eliminate sickle cell crises, but difficult stem‑cell collection is delaying access and exposing fragile gene‑therapy infrastructure.
The FDA’s oversight was built for devices that rarely change. Clinical AI evolves over time, raising new questions about who is responsible for ensuring its safety.
A new study from Harvard University finds that people who live closer to nuclear power plants have a higher risk of dying from cancer than those further away.